Disseminated gonococcal infection in a patient with paroxysmal nocturnal hemoglobinuria having received ravulizumab and meningococcal vaccine
Journal
Journal of Microbiology, Immunology and Infection
Journal Volume
53
Journal Issue
4
Pages
660-662
Date Issued
2020
Author(s)
Other Subjects
acyw 135; azithromycin; C reactive protein; ceftriaxone; Haemophilus influenzae type b vaccine; hepatitis A vaccine; Meningococcus vaccine; Pneumococcus vaccine; ravulizumab; antiinfective agent; complement inhibitor; Meningococcus vaccine; monoclonal antibody; ravulizumab; acute disease; adult; anemia; ankle pain; arthralgia; case report; clinical article; disease severity; disseminated gonococcal infection; drug dose reduction; dyspnea; fever; gonorrhea; hand disease; head and neck disease; headache; human; infection prevention; knee pain; Letter; maculopapular rash; male; meningococcosis; paroxysmal nocturnal hemoglobinuria; petechia; rash; rhinorrhea; rigidity; single drug dose; sore throat; unprotected sex; young adult; bacteremia; drug effect; gonorrhea; isolation and purification; microbial sensitivity test; multidrug resistance; Neisseria gonorrhoeae; paroxysmal nocturnal hemoglobinuria; pathology; treatment outcome; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Bacteremia; Complement Inactivating Agents; Drug Resistance, Multiple, Bacterial; Gonorrhea; Hemoglobinuria, Paroxysmal; Humans; Male; Meningococcal Vaccines; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Treatment Outcome; Young Adult
Publisher
Elsevier Ltd
Type
letter